1.上海中医药大学中药现代制剂技术教育部工程研究中心(上海 201203)
2.正大青春宝药业有限公司(浙江 杭州 310000)
张卓钰,女,在读硕士生,主要从事中药新药研发
刘敏臣,副研究员,硕士生导师;E-mail:liuminchen@shutcm.edu.cn
张继全,教授级高级工程师,硕士生导师;E-mail:jqzhang@shutcm.edu.cn
扫 描 看 全 文
张卓钰,李静慧,王馨等.抗甲方颗粒流化床制粒工艺优化及制剂质量评价研究[J].上海中医药大学学报,2022,36(04):52-58.
ZHANG Zhuoyu,LI Jinghui,WANG Xin,et al.Study on optimization of fluidized bed granulation process for Anti⁃Hashimoto’s Thyroiditis Formula Granules and preparation quality evaluation[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(04):52-58.
张卓钰,李静慧,王馨等.抗甲方颗粒流化床制粒工艺优化及制剂质量评价研究[J].上海中医药大学学报,2022,36(04):52-58. DOI: 10.16306/j.1008-861x.2022.04.008.
ZHANG Zhuoyu,LI Jinghui,WANG Xin,et al.Study on optimization of fluidized bed granulation process for Anti⁃Hashimoto’s Thyroiditis Formula Granules and preparation quality evaluation[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(04):52-58. DOI: 10.16306/j.1008-861x.2022.04.008.
目的,2,优化抗甲方颗粒流化床制粒工艺,以提高制剂处方的载药量,进而对获得的颗粒剂开展质量评价研究。,方法,2,以颗粒的制备可行性、成型率、颗粒粒径、流动性为评价指标,对流化床制粒的初始物料温度、进风温度、浓缩液密度进行单因素考察;建立HPLC方法测定颗粒中的毛蕊异黄酮苷和迷迭香酸含量,并采用《中国药典》方法对制剂开展水分、粒度和溶化性等项目检查。,结果,2,优化后的制粒参数为初始物料温度(38±1)℃,进风温度70 ℃,浓缩液密度为1.24~1.26 g/cm,3, (25 ℃);制得颗粒载药量为72%,较工艺优化前提高了约50%。所得制剂中毛蕊异黄酮苷和迷迭香酸含量分别为0.298 3 mg/g和0.989 5 mg/g;同时,其水分、粒度和溶化性等检查项目均符合药典要求。,结论,2,本研究所得制剂工艺稳定可行、载药量高,相关的质量研究工作可为进一步制定制剂的质量标准奠定基础。
Objective: The fluidized bed granulation process of anti-Hashimoto’s thyroiditis Formula Granules was optimized to improve the drug loading capacity of the formulation, and then the quality evaluation of the obtained granules was carried out accordingly.,Methods,2,Taking preparation feasibility, forming rate, particle size and fluidity of granules as evaluation indexes, the initial material temperature, inlet air temperature and concentrated solution density of fluidized bed granulation were investigated by single factor experiment. HPLC method was established for content determination of calycosin-7-,O,-β-,D,-glucoside and rosmarinic acid in the granules, and the moisture, particle size and solubility of the granules were examined by ,Chinese Pharmacopoeia’s, methods.,Results,2,The optimized granulation parameters were as follows: initial material temperature (38±1)℃, air inlet temperature 70℃, concentrated liquid density was 1.24~1.26 g/cm,3, (25 ℃). The drug loading of the obtained granules was 72%, which was about 50% higher than that before optimization. The contents of calycosin-7-,O,-β-,D,-glucoside and rosmarinic acid in the obtained preparation were 0.298 3 mg/g and 0.989 5 mg/g, respectively. Meanwhile, its moisture, particle size and solubility and other inspection items all met the requirements of ,Chinese Pharmacopoeia,.,Conclusion,2,The preparation process obtained in this study is stable and feasible, and the drug loading capacity is high. The related quality research can lay a foundation for further formulation of quality standard of the preparation.
抗甲方流化床工艺优化颗粒剂毛蕊异黄酮苷迷迭香酸含量测定
Anti-Hashimoto’s Thyroiditis Formula Granulesfluidized bed process optimizationgranulacalycosin-7-O-β-D-glucosiderosmarinic acidcontent determination
李更青,吴飞,胡佳亮,等. 基于制剂原料物理性质的抗甲方颗粒干法制粒工艺研究[J].中草药,2018,49(3):575-581.
王巍,唐永和,鞠海. 浅谈使用一步沸腾制粒机的经验[J]. 中国医院药学杂志,2006,26(2):231-232.
汤建成,陈丹菲,王溶溶. 参麦颗粒流化床制粒工艺中塌床问题的研究[J]. 药学服务与研究,2021,21(1):23-25.
张小飞,果秋婷. 盐酸二甲双胍流化床制粒工艺的影响因素研究[J]. 中国药师,2017,20(12):2145-2149.
国家药典委员会. 中华人民共和国药典:一部[M]. 北京:中国医药科技出版社,2020.
王丽,高家荣,韩燕全,等. 养肝益水颗粒成型工艺[J]. 中国实验方剂学杂志,2012,18(1):32-35.
张文,余雅婷,赵立杰,等. 共聚维酮改善金银花粉末压缩成型性能的研究[J]. 药学学报,2021,56(8):2127-2135.
杨群,胡晓莉,张锴,等. 基于粉体学表征技术的浙贝母配方颗粒处方和工艺研究[J].中草药,2018,49(15):3632-3638.
王新建,化宏伟,刘会东. 中药醇提取液的流化沸腾制粒研究[J]. 中成药,2007,29(10):1514-1515.
龙敏玲,汪涛,陈理,等. 菊花莲子植物固体饮料流化床制粒工艺研究[J]. 中国医药导报,2013,10(9):105-108.
曾佳,黄婷,俸灵林,等. 流化床制粒数值模拟技术研究进展[J]. 中国新药杂志,2019,28(11):1330-1342.
LIM D H,LETONA A,LEE M,et al. Fluidized-bed granulation of probiotics-encapsulated spray-dried skim milk powder:effects of a fluidizing aid, moisture-activation and dehydration [J]. Foods,2021,10(7):1600.
刘德丽,包华音,刘杨. 近5年黄芪化学成分及药理作用研究进展[J]. 食品与药品,2014,16(1):68-70.
曹雯,张文娟,潘金凤,等. 迷迭香酸药理作用的研究进展[J]. 广西中医药,2019,42(1):54-58.
李更青,吴飞,赵春草,等. 抗甲方浓缩工艺可靠性的指标性成分研究[J]. 时珍国医国药,2018,29(3):591-594.
0
浏览量
487
下载量
0
CSCD
1
CNKI被引量
关联资源
相关文章
相关作者
相关机构